Ob
Obseva (XOMA)
Geneva CHFounded 201230 employees
Private CapbiotechAcquiredWomen's Health
Platform: Linzagolix Gyn
Market Cap
N/A
All Drugs
3
Clinical Trials
7
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| OBS-1681 | OBS-1681 | Phase 3 | 4 | CD123 | MDS | ||
| Ivozumab | OBS-2705 | Phase 1 | 1 | RET | HCCRA | ||
| OBS-7968 | OBS-7968 | Approved | 2 | JAK2 | Huntington's |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (7)